Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Location contact
Erin Donahue, PhD
CONTACT
Robert M Richardson, MD PhD
CONTACT
NCT Number: NCT04286308
In this research study the researchers want to learn more about brain activity related to speech perception and production.
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02114, United States
Location status: Recruiting
Erin Donahue, PhD
CONTACT
Robert M Richardson, MD PhD
CONTACT
Speech production is disrupted in a number of neurological diseases that involve the basal ganglia, including Parkinson's disease (PD) and dystonia. The investigators will use a novel experimental approach and combination of analytic techniques to elucidate the contribution of neural activity in cortical-basal ganglia circuits to the hierarchical control of speech production, in subjects undergoing deep brain stimulation surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electrophysiological data collection at the time of DBS surgery.
Time frame: Duration of single DBS surgery
The number of subjects providing the interpretable speech related electrophysiological data during DBS surgery.
Contact information is provided by the study sponsor or research team.
Erin Donahue, PhD
CONTACT
Mark Richardson, MD, PhD
CONTACT
Massachusetts General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03664609
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06553625
Basal Ganglia Diseases, Brain Diseases
Cologne, Germany
View Trial DetailsNCT04071847
Basal Ganglia Diseases, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05317390
Basal Ganglia Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial Details